The Role of PANoptosis‐Related Genes in Predicting Breast Cancer Survival and Immune Prospect
BioMed Research International · 2025
DOI: 10.1155/bmri/3423698 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioMed Research International, 2025. Verfasst von Yuxi Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The First Affiliated Hospital With Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
The function of PANoptosis in breast cancer (BC) remains indistinct. We constructed a nomogram model to predict the prognosis of BC to identify high‐risk patients and help them receive more accurate treatment.
Method
We used Cox regression and least absolute shrinkage and selection operator (LASSO) algorithm to select PANoptosis‐related genes (PRGs) and calculated the PANoptosis‐related score (PRS) by LASSO coefficient. Through functional enrichment, somatic mutation, and tumor microenvironment (TME) analysis, we completed the identification of PANoptosis‐related immune cells and difference analysis of drug sensitivity and then verified key genes by performing survival analysis.
Results
Patients were divided into low‐ and high‐risk cohorts depending on PRS, and the negative association between risk scores and overall survival was disclosed. Analysis showed that differentially expressed genes in the two risk cohorts were mainly concentrated among pathways related to the immune system. Moreover, we detected distinguished differences in immune checkpoints, tumor mutation load, and TME in the two cohorts. Furthermore, KLHDC7B, GNG8, IGKV1OR2‐108, and IGHD were identified as key genes. We also found that hub genes were highly expressed in tumor tissues, while B cells, CD4+, and CD8+ T cells pretended to be positive among the hub gene–negative cohort. Prognosis analysis showed that pivotal genes had adverse effects on survival over time.
Conclusion
We built a precise prediction model based on risk scores and proved the significance of PRGs in BC TME and medicine sensitivity regulation, providing key perception for subsequent molecular mechanism studies and contributing to more personalized treatment decisions in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, The First Affiliated Hospital With Nanjing Medical University, Nanjing, China.
- Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China.
- Department of Breast, Renmin Hospital of Wuhan University, Wuhan, China.
ORCID-Profile: Yuxi Zhang, Zheming Liu, Yixuan Zhang, Xue Zhang, Yi Yao, Chi Zhang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, Y., Liu, Z., Zhang, Y., Zhang, X., Yao, Y., & Zhang, C. (2025). The Role of PANoptosis‐Related Genes in Predicting Breast Cancer Survival and Immune Prospect. BioMed Research International. https://doi.org/10.1155/bmri/3423698
Vancouver
Zhang Y, Liu Z, Zhang Y, Zhang X, Yao Y, Zhang C. The Role of PANoptosis‐Related Genes in Predicting Breast Cancer Survival and Immune Prospect. BioMed Research International. 2025. doi:10.1155/bmri/3423698
BibTeX
@article{Zhang2025,
author = {Zhang, Yuxi and Liu, Zheming and Zhang, Yixuan and Zhang, Xue and Yao, Yi and Zhang, Chi},
title = {The Role of PANoptosis‐Related Genes in Predicting Breast Cancer Survival and Immune Prospect},
journal = {BioMed Research International},
year = {2025},
doi = {10.1155/bmri/3423698}
}
EUVIMED